ITR is headed to San Francisco for Biotech Showcase & RESI.

Whether you’re advancing cell & gene therapies, vaccines, biologics, or small-molecule programs, our scientists support every stage of development through integrated in vivo, in vitro, and in silico toxicology — including GLP-compliant, BSL-2 capable studies.

Connect with Gregg Nyhus and Ilan Rose at Biotech Showcase, and Mihai Anghel at RESI, if you’re looking for a trusted preclinical development partner.